Borg, J
Cervenka, S
Kuja-Halkola, R
Matheson, G J
Jönsson, E G
Lichtenstein, P http://orcid.org/0000-0003-3037-5287
Henningsson, S
Ichimiya, T
Larsson, H
Stenkrona, P
Halldin, C
Farde, L
Article History
Received: 24 February 2015
Revised: 10 July 2015
Accepted: 5 August 2015
First Online: 6 October 2015
Competing interests
: Dr JB has received compensation as a member of the scientific advisory board of Astra Zeneca. Dr SC has received grant support from Astra Zeneca as co-investigator, and has served as a one-off speaker for Roche and Otsuka pharmaceuticals. Dr LF is partially employed at the Astra Zeneca Translational Science Center at Karolinska Institutet. The remaining authors declare no conflict of interest.